Douglas Tremblay, M.D

Rare Disease / Clinical Research

Tisch Cancer Institute

NEW YORK, NY, USA. Electronic address: douglas.tremblay@mssm.edu

QC-verified· April 2026 2 publicationsNPI: 1972921807

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Myeloproliferative neoplasm

Verify independently

PubMed author search
NPPES NPI registry entry

Other specialists for Myeloproliferative neoplasm

Peers ranked by clinical-trial PI role, publications, and verification quality.

Jean-Jacques Kiladjian
(France) Clinical Investigations Center, Saint-Louis Hospital, Paris, France
Rupen Hargreaves
University College London Hospitals
Jie Yang
Heibei General Hospital
Shayeri Chowdhury
Indian Institute of Technology Delhi
Raajit K Rampal, MD
Memorial Sloan Kettering Cancer Center
NY
Donal P McLornan
University College Hospitals
Saurabh Shrivastva
Indian Institute of Technology Delhi
Aditi Singh
Indian Institute of Technology Delhi

See all specialists for Myeloproliferative neoplasm →

← Back to specialists directory